본문 바로가기
KERD
논문KCI 등재

근거중심 의약품 정책 결정; 극복하기 어려운 과제인가? 한국 전문가의 생생한 의견

Evidence-based Pharmaceutical Policy-making; A Challenging Task? Vivid Voices from Korean Experts

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류약학

초록

This study aims to explore the difficulties of evidence-based pharmaceutical policy-making in the Korean context where several pharmaceutical policies were introduced within a short period. Semi-structured in-depth interviews were performed with eight experts in the Korean pharmaceutical arena. The key challenge in Korean situation might be the apparent lack of available evidence caused by the limited resources, the lack of policy consistency and coordination ability in the authorities and distrust across stakeholders. To build an evidencebased tradition, it is essential to resolve the tangible lack. At once, more fundamental changes seem to be required in the intangible policy environments.

Abstract

This study aims to explore the difficulties of evidence-based pharmaceutical policy-making in the Korean context where several pharmaceutical policies were introduced within a short period. Semi-structured in-depth interviews were performed with eight experts in the Korean pharmaceutical arena. The key challenge in Korean situation might be the apparent lack of available evidence caused by the limited resources, the lack of policy consistency and coordination ability in the authorities and distrust across stakeholders. To build an evidencebased tradition, it is essential to resolve the tangible lack. At once, more fundamental changes seem to be required in the intangible policy environments.

참고문헌 (38)

  1. Wilson DC, "Using researchbased knowledge to underpin waste and resources policy", Waste Manage Res, 25, pp.247~256 (2007)
  2. van Kammen J, "Using knowledge brokering to promote evidence-based policy-making: The need for support structures", Bulletin of the World Health Organization, 84, pp.608~612 (2006)
  3. Department of Health, "Policy research programme : purpose, objectives and priorities" (2008), Department of Health
  4. Soumerai SB, "Determinants of change in Medicaid pharmaceutical cost sharing: does evidence affect policy?", Milbank Quarterly, 75, pp.11~34 (2007)
  5. Cho JG, "Evaluation and policy implication of the Separation of prescribing and dispensing drugs", Korea Institute for Health and Social Affairs, ~ (2001)
  6. Cho JG, "Monitoring health care utilisation behaviour after the inception of the separation of prescribing and dispensing drugs", Korea Institute for Health and Social Affairs, ~ (2002)
  7. Jang SM, "Pharmaceutical utilisation before and after the separation of prescribing and dispensing of drugs; focusing on changes in prescribing behaviour", Korea Institute for Health and Social Affairs, ~ (2001)
  8. Lee EK, "Comparison of peptic-ulcer drug use and expenditures before and after the implementation of a government policy to separate prescribing and dispensing practices in South Korea", Clin Ther, 25, pp.578~592 (2003)
  9. Lee IH, "The effects of new pricing and copayment schemes for pharmaceuticals in South Korea", Health Policy, 104, pp.40~49 (2012)
  10. Healy, D, "The new medical oikumene, In Global pharmaceuticals" (2006), Duke University Press
  11. Lovell, A. M, "Addiction markets: the case of high-dose buprenorphine in France, In Global pharmaceuticals" (2006), Duke University Press
  12. Jacobzone, S, "Pharmaceutical policies in OECD countries: reconciling social and industrial goals", Organisation for Economic Co-operation and Development, ~ (2000)
  13. Denscombe, "The good research guide for small-scale social research projects", pp.7~34 (2007), Open University Press
  14. Patton, M. Q, "Designing qualitative studies. Qualitative evaluation and research methods", pp.143~198 (1990), SAGE Publications
  15. Guest G, "How many interviews are enough? An experiment with data saturation and variability", Field Methods, 18, pp.59~82 (2006)
  16. Leech, NL, "The role of sampling in qualitative research", Academic Exchange Quarterly, 9, pp.280~284 (2005)
  17. Adamson J, "'Questerviews': using questionnaires in qualitative interviews as a method of integrating qualitative and quantitative health services research", J Health Serv Res Policy, 9, pp.139~145 (2004)
  18. Framework; the qualitative data analysis tool, "National Centre for Social Research", National Centre for Social Research, ~ (2010)
  19. Ritchie J, "Qualitative data analysis for applied policy research, In Analysing qualitative data", pp.173~194 (1994), Routledge
  20. Marshall C, "Data collection methods. Designing qualitative research", pp.97~150 (2006), Sage Publications
  21. Klein R, "Learning from others: shall the last be the first?", J Health Politics Policy Law, 22, pp.1267~1278 (1997)
  22. Rose R, "why learn lessons from abroad?, In Learning from comparative public policy: a practical guide" (2005), Routledge
  23. Salter B, "Doctors and managers. The new politics of medicine", pp.68~92 (2004), Basingstoke
  24. Harrison S, "Managing health care: balancing interests and influence, In Dilemmas in health care" (1993), Open University Press
  25. Ameringer CF, "Federal antitrust policy and physician discontent : defining moments in the struggle for congressional relief", J Health Politics Policy Law, 27, pp.543~574 (2002)
  26. DailyPharm, "Doctors' representatives, "stop the generic prescribing programme"", ~ (2007)
  27. DailyPharm, "Medical academy doubts the quality of generic products", ~ (2007)
  28. DailyPharm, "ead director of NMC Dr. Kang, "pharmacists would dispense profitable products under a generic prescribing programme", ~ (2007)
  29. Danzon PM, "Does regulation drive out competition in pharmaceutical markets?", J Law Econ, 43, pp.311~357 (2000)
  30. Danzon PM, "Prices and availability of pharmaceuticals: evidence from nine countries", Health Aff (2003)
  31. Guillen AM, "Reforming pharmaceutical policies in the European Union: a "penguin effect"?", Int J Health Serv, 33, pp.1~28 (2003)
  32. 이수연, "세계화와 국민국가의 복지정책 자율성: 다국적 제약자본이 우리나라 제약정책 결정에 미친 영향을 중심으로", 한국사회복지학, 57(3), pp.5~30 (2005), 한국사회복지학회
  33. 이수연, "다국적 제약자본의 지적재산권 보호 對 국민 건강권 보장간의 갈등", 사회복지연구, 23(23), pp.139~167 (2004), 한국사회복지연구회
  34. DongA IIbo, "US urged Korean government to give up the PERP", Dong-A Ilbo, ~ (2006)
  35. Cookson, R, "Evidence-based policy making in health care : what it is and what it isn't", J Health Serv Res Policy, 10, pp.118~121 (2005)
  36. Innvaer S, "Health policymakers' perceptions of their use of evidence : a systematic review", J Health Serv Res Policy, 7, pp.239~244 (2002)
  37. Choi BC, "Can scientists and policy makers work together?", J Epidemiol Commun H, 59, pp.632~637 (2005)
  38. Sharpe M, "Weighing the evidence: prospects for evidence-based policy-making", J Environ Monitor, 6, pp.114N~117N (2004)

관련 논문AI추천

이 간행물의 다른 논문 (10건)